M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 697-704

  Zhang, Hong Mei ^a   Li, De Pei ^a   Chen, Shao Rui ^a   Pan, Hui Lin ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; HIMBACINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MT 3 TOXIN; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE M; PERTUSSIS TOXIN; RECEPTOR SUBTYPE; TOXIN; UNCLASSIFIED DRUG; OXOTREMORINE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; GABAERGIC SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD DORSAL HORN; VOLTAGE CLAMP; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; IN VITRO STUDY; PHYSIOLOGY; POSTERIOR HORN CELL; RAT; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; OXOTREMORINE; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; SYNAPTIC TRANSMISSION;

EID: 18044366205     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.079939     Document Type: Article

References (40)

1. Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, and Yoshimura M (1998) Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol 508:83-93.
2. Barber RP, Vaughn JE, Saito K, McLaughlin BJ, and Roberts E (1978) GABAergic terminals are presynaptic to primary afferent terminals in the substantia gelatinosa of the rat spinal cord. Brain Res 141:35-55.
3. Caulfield MP (1993) Muscarinic receptors: characterization, coupling and function. Pharmacol Ther 58:319-379.
4. Caulfield MP and Birdsall NJ (1998) International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290.
5. Chen SR and Pan HL (2003) Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res 965:67-74.
6. Chen SR and Pan HL (2004) Activation of muscarinic receptors inhibits spinal dorsal horn projection neurons: role of GABAB receptors. Neuroscience 125:141-148.
7. Doller D, Chackalamannil S, Czarniecki M, McQuade R, and Ruperto V (1999) Design, synthesis and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists. Bioorg Med Chem Lett 9:901-906.
8. Dorje F, Wess J, Lambrecht G, Tacke R, Mutschler E, and Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
9. Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, and Wess J (2002) Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 62:1084-1093.
10. Ehlert FJ (1996) The interaction of 4-DAMP mustard with subtypes of the muscarinic receptor. Life Sci 58:1971-1978.
11. Ellis JL, Harman D, Gonzalez J, Spera ML, Liu R, Shen TY, Wypij DM, and Zuo F (1999) Development of muscarinic analgesics derived from epibatidine: role of the M4 receptor subtype. J Pharmacol Exp Ther 288:1143-1150.
12. Felder CC (1995) Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9:619-625.
13. Fields TA and Casey PJ (1997) Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321:561-571.
14. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, and Wess J (1999) Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 96:1692-1697.
15. Hoglund AU and Baghdoyan HA (1997) M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord. J Pharmacol Exp Ther 281:470-477.
16. Hood DD, Mallak KA, James RL, Tuttle R, and Eisenach JC (1997) Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition. J Pharmacol Exp Ther 282:86-92.
17. Iwamoto ET and Marion L (1993) Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. J Pharmacol Exp Ther 266:329-338.
18. Jolkkonen M, van Giersbergen PL, Hellman U, Wernstedt C, and Karlsson E (1994) A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett 352:91-94.
19. Li DP, Chen SR, Pan YZ, Levey AI, and Pan HL (2002) Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol 543:807-818.
20. Liang JS, Carsi-Gabrenas J, Krajewski JL, McCafferty JM, Purkerson SL, Santiago MP, Strauss WL, Valentine HH, and Potter LT (1996) Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon 34:1257-1267.
21. Liu YF, Ghahremani MH, Rasenick MM, Jakobs KH, and Albert PR (1999) Stimulation of cAMP synthesis by Gi-coupled receptors upon ablation of distinct Galphai protein expression. Gi subtype specificity of the 5-HT1A receptor. J Biol Chem 274:16444-16450.
22. Lu Y and Perl ER (2003) A specific inhibitory pathway between substantia gelatinosa neurons receiving direct C-fiber input. J Neurosci 23:8752-8758.
23. Ma HC, Dohi S, Wang YF, Ishizawa Y, and Yanagidate F (2001) The antinociceptive and sedative effects of carbachol and oxycodone administered into brainstem pontine reticular formation and spinal subarachnoid space in rats. Anesth Analg 92:1307-1315.
24. Miller JH, Aagaard PJ, Gibson VA, and McKinney M (1992) Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors. J Pharmacol Exp Ther 263:663-667.
25. Mulugeta E, El-Bakri N, Karlsson E, Elhassan A, and Adem A (2003) Loss of muscarinic M4 receptors in spinal cord of arthritic rats: implications for a role of M4 receptors in pain response. Brain Res 982:284-287.
26. Naguib M and Yaksh TL (1994) Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology 80:1338-1348.
27. Naguib M and Yaksh TL (1997) Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg 85:847-853.
28. Nevo I, Avidor-Reiss T, Levy R, Bayewitch M, Heldman E, and Vogel Z (1998) Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors. Mol Pharmacol 54:419-426.
29. Pan YZ, Li DP, and Pan HL (2002) Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. J Neurophysiol 87:1938-1947.
30. Pan YZ and Pan HL (2004) Primary afferent stimulation differentially potentiates excitatory and inhibitory inputs to spinal lamina II outer and inner neurons. J Neurophysiol 91:2413-2421.
31. Scatton B, Dubois A, Javoy-Agid F, and Camus A (1984) Autoradiographic localization of muscarinic cholinergic receptors at various segmental levels of the human spinal cord. Neurosci Lett 49:239-245.
32. Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, and Sauerberg P (1997) M1 receptor agonist activity is not a requirement for muscarinic antinociception. J Pharmacol Exp Ther 281:868-875.
33. Villiger JW and Faull RL (1985) Muscarinic cholinergic receptors in the human spinal cord: differential localization of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding sites. Brain Res 345:196-199.
34. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69-99.
35. Wong CS, Su YF, Chang KJ, and Watkins WD (1992) Intrathecal pertussis toxin treatment attenuates opioid antinociception and reduces high-affinity state of opioid receptors. Anesthesiology 77:691-699.
36. Yamamura HI, Wamsley JK, Deshmukh P, and Roeske WR (1983) Differential light microscopic autoradiographic localization of muscarinic cholinergic receptors in the brainstem and spinal cord of the rat using [3H]pirenzepine. Eur J Pharmacol 91:147-149.
37. Yigit M, Keipert C, and Backus KH (2003) Muscarinic acetylcholine receptors potentiate the GABAergic transmission in the developing rat inferior colliculus. Neuropharmacology 45:504-513.
38. Yoshimura M and Jessell T (1990) Amino acid-mediated EPSPs at primary afferent synapses with substantia gelatinosa neurones in the rat spinal cord. J Physiol 430:315-335.
39. Yung KK and Lo YL (1997) Immunocytochemical localization of muscarinic m2 receptor in the rat spinal cord. Neurosci Lett 229:81-84.
40. Zhuo M and Gebhart GF (1991) Tonic cholinergic inhibition of spinal mechanical transmission. Pain 46:211-222.